STAT5-dependent regulation of CDC25A by miR-16 controls proliferation and differentiation in FLT3-ITD acute myeloid leukemia

por Sueur, Gabrielle, Boutet, Alison, Gotanègre, Mathilde, Mansat-De Mas, Véronique, Besson, Arnaud, Manenti, Stéphane, Bertoli, Sarah
Publicado 2020

Physician uncertainty aversion impacts medical decision making for older patients with acute myeloid leukemia: results of a national survey

por Bories, Pierre, Lamy, Sébastien, Simand, Célestine, Bertoli, Sarah, Delpierre, Cyrille, Malak, Sandra, Fornecker, Luc, Moreau, Stéphane, Récher, Christian, Nebout, Antoine
Publicado 2018

Outcome of patients aged 60‐75 years with newly diagnosed secondary acute myeloid leukemia: A single‐institution experience

por Bertoli, Sarah, Tavitian, Suzanne, Bories, Pierre, Luquet, Isabelle, Delabesse, Eric, Comont, Thibault, Sarry, Audrey, Huguet, Françoise, Bérard, Emilie, Récher, Christian
Publicado 2019

Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older pat...

por Berger, Eloïse, Delpierre, Cyrille, Despas, Fabien, Bertoli, Sarah, Bérard, Emilie, Bombarde, Oriane, Bories, Pierre, Sarry, Audrey, Laurent, Guy, Récher, Christian, Lamy, Sébastien
Publicado 2019

A case of cup‐like blasts associated with B‐lymphoblastic leukemia without NPM1 and FLT3 internal tandem duplication mutations

por Rieu, Jean‐Baptiste, Coster, Lucie, Corre, Jill, Tavitian, Suzanne, Recher, Christian, Huynh, Anne, Picard, Muriel, Derreumaux, Celine, Bertoli, Sarah, Vergez, Francois, Largeaud, Laetitia
Publicado 2020

Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy

por Cartel, Maëlle, Mouchel, Pierre-Luc, Gotanègre, Mathilde, David, Laure, Bertoli, Sarah, Mansat-De Mas, Véronique, Besson, Arnaud, Sarry, Jean-Emmanuel, Manenti, Stéphane, Didier, Christine
Publicado 2020

Prognostic impact of viral reactivations in acute myeloid leukemia patients undergoing allogeneic stem cell transplantation in first complete response

por Guenounou, Sarah, Borel, Cécile, Bérard, Emilie, Yon, Edwige, Fort, Marylise, Mengelle, Catherine, Bertoli, Sarah, Sarry, Audrey, Tavitian, Suzanne, Huguet, Françoise, Attal, Michel, Récher, Christian, Huynh, Anne
Publicado 2016

Improved outcome for AML patients over the years 2000–2014

por Bertoli, Sarah, Tavitian, Suzanne, Huynh, Anne, Borel, Cécile, Guenounou, Sarah, Luquet, Isabelle, Delabesse, Eric, Sarry, Audrey, Laurent, Guy, Attal, Michel, Huguet, Françoise, Bérard, Emilie, Récher, Christian
Publicado 2017

Cost comparison of post-remission strategies in younger and older AML patients in France

por Mounie, Michael, Dumas, Pierre-Yves, Liva-Yonnet, Sandra, Fabre, Didier, Leguay, Thibault, Galtier, Jean, Berard, Emilie, Hanta, Ramaroson, Gilleron, Véronique, Bertoli, Sarah, Pigneux, Arnaud, Récher, Christian, Costa, Nadège
Publicado 2023

PB1764: SEGMENTATION AND CLASSIFICATION OF BONE MARROW CELLS FROM MULTI-PRECISION NUMERIZATION OF BONE MARROW SMEARS (BMS) FROM PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) USING AI...

por Bennis, Achraf, Leleux, Philippe, Canali, Alban, Pourtales, Caroline De, Mouysset, Sandrine, Simoncini, David, Brousset, Pierre, Frenois, Francois-Xavier, Recher, Christian, Alliot, Jean-Marc, Rieu, Jean-Baptiste, Bertoli, Sarah
Publicado 2023

Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies

por Bertoli, Sarah, Sterin, Arthur, Tavitian, Suzanne, Oberic, Lucie, Ysebaert, Loïc, Bouabdallah, Reda, Vergez, François, Sarry, Audrey, Bérard, Emilie, Huguet, Françoise, Laurent, Guy, Prébet, Thomas, Vey, Norbert, Récher, Christian
Publicado 2016

Vitamin C and D supplementation in acute myeloid leukemia

por Mouchel, Pierre Luc, Bérard, Emilie, Tavitian, Suzanne, Gadaud, Noémie, Vergez, François, Rieu, Jean Baptiste, Luquet, Isabelle, Sarry, Audrey, Huguet, Françoise, Largeaud, Laetitia, Delabesse, Eric, Huynh, Anne, Bertoli, Sarah, Récher, Christian
Publicado 2023

Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia

por Dumas, Pierre-Yves, Bertoli, Sarah, Bérard, Emilie, Médiavilla, Clémence, Yon, Edwige, Tavitian, Suzanne, Leguay, Thibaut, Huguet, Françoise, Forcade, Edouard, Milpied, Noël, Sarry, Audrey, Sauvezie, Mathieu, Bories, Pierre, Pigneux, Arnaud, Récher, Christian
Publicado 2017

CD34(+)CD38(−)CD123(+) Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents

por Vergez, François, Nicolau-Travers, Marie-Laure, Bertoli, Sarah, Rieu, Jean-Baptiste, Tavitian, Suzanne, Bories, Pierre, Luquet, Isabelle, De Mas, Véronique, Largeaud, Laetitia, Sarry, Audrey, Huguet, Françoise, Delabesse, Eric, Bérard, Emilie, Récher, Christian
Publicado 2020

Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes

por Devillier, Raynier, Mansat-De Mas, Véronique, Gelsi-Boyer, Veronique, Demur, Cecile, Murati, Anne, Corre, Jill, Prebet, Thomas, Bertoli, Sarah, Brecqueville, Mandy, Arnoulet, Christine, Recher, Christian, Vey, Norbert, Mozziconacci, Marie-Joelle, Delabesse, Eric, Birnbaum, Daniel
Publicado 2015

Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine

por Bories, Pierre, Prade, Naïs, Lagarde, Stéphanie, Cabarrou, Bastien, Largeaud, Laetitia, Plenecassagnes, Julien, Luquet, Isabelle, De Mas, Véronique, Filleron, Thomas, Cassou, Manon, Sarry, Audrey, Fornecker, Luc-Matthieu, Simand, Célestine, Bertoli, Sarah, Recher, Christian, Delabesse, Eric
Publicado 2020

Genomic landscape of hyperleukocytic acute myeloid leukemia

por Largeaud, Laetitia, Bertoli, Sarah, Bérard, Emilie, Tavitian, Suzanne, Picard, Muriel, Dufrechou, Stéphanie, Prade, Naïs, Vergez, François, Rieu, Jean Baptiste, Luquet, Isabelle, Sarry, Audrey, Huguet, Françoise, Ruiz, Jean, De Mas, Véronique, Delabesse, Eric, Récher, Christian
Publicado 2022

Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience

por LaRochelle, Olivier, Bertoli, Sarah, Vergez, François, Sarry, Jean-Emmanuel, Mansat-De Mas, Véronique, Dobbelstein, Sophie, Dastugue, Nicole, Strzelecki, Anne-Claire, Cavelier, Cindy, Creancier, Laurent, Pillon, Arnaud, Kruczynski, Anna, Demur, Cécile, Sarry, Audrey, Huguet, Françoise, Huynh, Anne, Récher, Christian, Delabesse, Eric
Publicado 2011

Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2(V617F) myeloproliferative neoplasms

por Courdy, Charly, Platteeuw, Loïc, Ducau, Charlotte, De Araujo, Isabelle, Boet, Emeline, Sahal, Ambrine, Saland, Estelle, Edmond, Valérie, Tavitian, Suzanne, Bertoli, Sarah, Cougoul, Pierre, Granat, Fanny, Poillet, Laura, Marty, Caroline, Plo, Isabelle, Sarry, Jean-Emmanuel, Manenti, Stéphane, Mansat-De Mas, Véronique, Joffre, Carine
Publicado 2023

Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study

por Dumas, Pierre-Yves, Bertoli, Sarah, Bérard, Emilie, Largeaud, Laetitia, Bidet, Audrey, Delabesse, Eric, Leguay, Thibaut, Leroy, Harmony, Gadaud, Noémie, Rieu, Jean Baptiste, Vial, Jean-Philippe, Vergez, François, Lechevalier, Nicolas, Luquet, Isabelle, Klein, Emilie, Sarry, Audrey, de Grande, Anne-Charlotte, Pigneux, Arnaud, Récher, Christian
Publicado 2020